Navigation Links
McAdams DeMarco Awarded $100,000 as First Arthritis-Aging Collaborative Researcher
Date:5/7/2013

Long Beach, CA and New York, NY (PRWEB) May 07, 2013

Mara McAdams DeMarco, Ph.D. of Johns Hopkins Medical Institutions in Maryland was awarded $100,000 to pursue her research on the risk factors and consequences of gout, a form of arthritis, in older adults. The Arthritis National Research Foundation (ANRF) and the American Federation for Aging Research (AFAR) jointly funded her work in their first-time collaboration of the Arthritis and Aging Research Grant.

Every year ANRF and AFAR award grants to early-stage investigators who are carrying out new and innovative research methods in arthritis and aging, respectively. This award is the first grant funded through a collaboration of ANRF and AFAR.

“This grant studying gout, a problem that afflicts more than three million Americans, fits perfectly into the mission of both organizations,” said ANRF Executive Director Helene Belisle. “The Arthritis National Research Foundation is delighted to pool its resources with AFAR to further research in arthritis and aging,”

Gout is a painful and potentially disabling form of arthritis that has been around since ancient times. The first symptoms are usually intense episodes of painful swelling in single joints, most often in the feet. Gout is an enormous public health problem in the older adults, yet the impact of the disease in the older adults has not been the subject of quality, targeted analysis. Dr. McAdams DeMarco will attempt to answer many important questions, such as whether gout is more disabling in older adults than in younger individuals.

Both nonprofit organizations view research as critical for new information that will ultimately benefit patients. This collaboration reinforces their respective approaches for funding research and ensures that only the best up-and-coming scientists receive support.

“AFAR’s collaboration with ANRF has identified a talented researcher whose work promises to illuminate an important intersection between aging biology and arthritis,” says Stephanie Lederman, EdM, Executive Director of AFAR.

Dr. McAdams DeMarco chose gout as her research topic because of its prevalence, rich history, and because she worked closely with the Department of Epidemiology and Division of Rheumatology at Johns Hopkins to develop her doctoral dissertation on gout. She feels confident that, with her extensive knowledge of the disease, she is well equipped to move the research forward in this area.

“This grant is the perfect opportunity for me to pursue this research interest and will help with my career development,” she said. “My goal is to apply the epidemiology of aging research methods to the understudied population of older adults with gout.”

Dr. McAdams DeMarco completed her doctoral degree in 2012 at Johns Hopkins University and has been a faculty instructor at Johns Hopkins for almost two years. She is well supported by the institution and positioned to succeed with her innovative research on gout.

“This is a unique and potentially high impact study,” added Belisle. “The funding priorities of ANRF and AFAR are so closely aligned and Dr. McAdams DeMarco is an outstanding representative for our first collaborative grant in arthritis and aging research.”

Read the full story at http://www.prweb.com/releases/gout/Arthritis-Aging-Research/prweb10707024.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
2. $9 million grant awarded to UH to study, treat learning disabilities
3. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
4. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
5. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
6. Southeast program to fight diabetes awarded nearly $10 million by HHS
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. 29 Johns Hopkins stem cell researchers awarded funding
9. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
10. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
11. EMBO Gold Medal 2012 awarded to Jiri Friml
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... , ... MelaKids, a Laredo-based company, has introduced a new concept for children’s ... gives us a full supply of melanin – in the back of the eye ... pigment; however, around the age of thirty, we develop a yellow-brown pigment in the ...
(Date:9/19/2017)... , ... September 19, 2017 , ... The Workgroup ... of health IT to create efficiencies in healthcare information exchange and a trusted advisor ... of their latest industry white paper, entitled Barriers to Adoption of the ERA ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the lack ... itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. Vitev ... alkaline water technologies, water filtration systems, and consumer education. , ...
(Date:9/19/2017)... ... September 19, 2017 , ... Bone Solutions Inc. (BSI), an ... orthopedic medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with ... magnesium, a critical property for bone health and development. , “We’re excited to ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team Decades, ... of making a distinct rather than generic impression in the job market if one ... a stack of resumes knows that the first impression they give off is not ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Sept. 6, 2017   PDI , a leader in ... host an educational session focused on the role of ... prevention at the 2017 Annual Scientific Meeting of the ... place at the Phoenix Convention ... Sept. 16-19, will also feature PDI,s Prevantics® Device ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... NEWTOWN, Pa. , Sept. 5, 2017  Xyntek Inc. has announced another ... opened a new Midwest office to meet the growing demands of customer engagements ... Xyntek's new Midwest office is located at ... ... demands of customer engagements regionally. ...
Breaking Medicine Technology: